Clinical trial
Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
NCT00943917 is registered in ClinicalTrials.gov with Intarcia Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
- Lead sponsor
- Intarcia Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- February 28, 2011
- Enrollment
- 155 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes